KAT2B and uremia: The precise mechanisms have yet to be identified for uremia and hypoxia, but the finding that KD-MSCs show downregulation of PCAF expression, poor angiogenesis activation in vivo, and blunting of the hypoxic response might be helpful in their elucidation in ESKD patients.